AU6683496A - Use of griseofulvin for inhibiting the growth of cancers - Google Patents

Use of griseofulvin for inhibiting the growth of cancers

Info

Publication number: AU6683496A
Authority: AU; Australia
Prior art keywords: griseofulvin; cancers; inhibiting; growth
Prior art date: 1995-08-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU66834/96A

Other versions

AU713031B2 (en

Inventor

James Berger Camden

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Procter and Gamble Co

Original Assignee

Procter and Gamble Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-03

Filing date

1996-07-30

Publication date

1997-03-05

1996-07-30 Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co

1997-03-05 Publication of AU6683496A publication Critical patent/AU6683496A/en

1999-11-18 Application granted granted Critical

1999-11-18 Publication of AU713031B2 publication Critical patent/AU713031B2/en

2016-07-30 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Virology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AU66834/96A 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers Ceased AU713031B2 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US183995P	1995-08-03	1995-08-03
US60/001839		1995-08-03
US67418196A	1996-07-16	1996-07-16
US08/674181		1996-07-16
PCT/US1996/012475 WO1997005870A2 (en)	1995-08-03	1996-07-30	Use of griseofulvin for inhibiting the growth of cancers

Publications (2)

Publication Number	Publication Date
AU6683496A true AU6683496A (en)	1997-03-05
AU713031B2 AU713031B2 (en)	1999-11-18

Family

ID=26669547

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU66834/96A Ceased AU713031B2 (en)	1995-08-03	1996-07-30	Use of griseofulvin for inhibiting the growth of cancers

Country Status (16)

Country	Link
EP (1)	EP0841914A2 (en)
JP (1)	JPH11511136A (en)
KR (1)	KR19990036137A (en)
AR (1)	AR003176A1 (en)
AU (1)	AU713031B2 (en)
BR (1)	BR9609920A (en)
CA (1)	CA2228503A1 (en)
CZ (1)	CZ30598A3 (en)
HU (1)	HUP9903506A3 (en)
IL (1)	IL123094A0 (en)
MX (1)	MX9800945A (en)
NO (1)	NO980420L (en)
PL (1)	PL324905A1 (en)
SK (1)	SK14298A3 (en)
TR (1)	TR199800244T2 (en)
WO (1)	WO1997005870A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6177460B1 (en)	1995-04-12	2001-01-23	The Procter & Gamble Company	Method of treatment for cancer or viral infections
US6479526B1 (en)	1995-04-12	2002-11-12	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en)	1995-04-12	2001-07-17	The Proctor & Gamble Company	Methods of treating cancer with benzimidazoles
US5770616A (en)	1995-06-07	1998-06-23	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en)	1995-06-07	2001-07-24	The Proctor & Gamble Company	Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en)	1995-08-04	2004-02-03	University Of Arizona Foundation	N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en)	1997-01-28	1999-05-04	The Procter & Gamble Company	Method for inhibiting the growth of cancers
US6506783B1 (en)	1997-05-16	2003-01-14	The Procter & Gamble Company	Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en)	1998-05-19	2001-06-12	The Procter & Gamble Company	HIV and viral treatment
CA2337690C (en) *	1998-07-27	2013-10-01	Texas Pharmaceuticals, Inc.	Chemically induced intracellular hyperthermia
TR200101299T2 (en) *	1998-11-09	2002-01-21	Idec Pharmaceuticals Corporation	Treating hematological malignancies related to circulating tumor cells using chimeric CD20-inhibitory antibody.
US6423734B1 (en)	1999-08-13	2002-07-23	The Procter & Gamble Company	Method of preventing cancer
US6407105B1 (en)	2000-09-26	2002-06-18	The Procter & Gamble Company	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en)	2000-09-26	2002-10-08	The Procter & Gamble Company	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en)	2000-09-26	2003-08-19	University Of Arizona Foundation	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en)	2000-09-26	2002-04-30	The Procter & Gamble Company	Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
JP4779298B2 (en) *	2001-06-25	2011-09-28	味の素株式会社	Antitumor agent
EP2008652A1 (en) *	2007-06-28	2008-12-31	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts	Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
EP2204367A1 (en) *	2008-12-22	2010-07-07	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts	Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

1996
- 1996-07-30 CA CA002228503A patent/CA2228503A1/en not_active Abandoned
- 1996-07-30 BR BR9609920A patent/BR9609920A/en unknown
- 1996-07-30 KR KR1019980700805A patent/KR19990036137A/en not_active Application Discontinuation
- 1996-07-30 EP EP96926807A patent/EP0841914A2/en not_active Withdrawn
- 1996-07-30 PL PL96324905A patent/PL324905A1/en unknown
- 1996-07-30 CZ CZ98305A patent/CZ30598A3/en unknown
- 1996-07-30 TR TR1998/00244T patent/TR199800244T2/en unknown
- 1996-07-30 IL IL12309496A patent/IL123094A0/en unknown
- 1996-07-30 AU AU66834/96A patent/AU713031B2/en not_active Ceased
- 1996-07-30 WO PCT/US1996/012475 patent/WO1997005870A2/en not_active Application Discontinuation
- 1996-07-30 JP JP9508495A patent/JPH11511136A/en active Pending
- 1996-07-30 HU HU9903506A patent/HUP9903506A3/en unknown
- 1996-07-30 SK SK142-98A patent/SK14298A3/en unknown
- 1996-07-30 MX MX9800945A patent/MX9800945A/en unknown
- 1996-08-02 AR ARP960103861A patent/AR003176A1/en not_active Application Discontinuation
1998
- 1998-01-30 NO NO980420A patent/NO980420L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO980420L (en)	1998-04-03
CA2228503A1 (en)	1997-02-20
AR003176A1 (en)	1998-07-08
MX9800945A (en)	1998-04-30
BR9609920A (en)	1999-07-06
HUP9903506A2 (en)	2000-06-28
WO1997005870A3 (en)	1997-04-17
CZ30598A3 (en)	1998-06-17
PL324905A1 (en)	1998-06-22
JPH11511136A (en)	1999-09-28
TR199800244T2 (en)	1998-09-21
AU713031B2 (en)	1999-11-18
SK14298A3 (en)	1998-09-09
IL123094A0 (en)	1998-09-24
NO980420D0 (en)	1998-01-30
WO1997005870A2 (en)	1997-02-20
EP0841914A2 (en)	1998-05-20
HUP9903506A3 (en)	2000-07-28
KR19990036137A (en)	1999-05-25

Publication	Publication Date	Title
AU5300996A (en)	1996-09-18	Use of angiogenesis suppressors for inhibiting hair growth
AU5040696A (en)	1996-10-10	Quinazoline derivatives
AU5343396A (en)	1996-11-18	Quinazoline derivatives
AU5343296A (en)	1996-11-18	Quinazoline derivatives
AU5343096A (en)	1996-11-18	Quinazoline derivatives
AU6683496A (en)	1997-03-05	Use of griseofulvin for inhibiting the growth of cancers
AU5788396A (en)	1996-11-21	Methods of inhibition or killing of cancer cells
AU6683396A (en)	1997-03-05	Use of fluconazole for inhibiting the growth of cancers
IL117873A0 (en)	1996-08-04	Pharmaceutical compositions for inhibiting the growth of viruses and cancers
ZA964377B (en)	1997-02-17	A pharmaceutical compositions for inhibiting the growth of cancers.
AU2871195A (en)	1996-01-19	Methods for the synthesis of diketopiperazines
IL117876A0 (en)	1996-08-04	Pharmaceutical compositions for inhibiting the growth of viruses and cancers
AU5871196A (en)	1996-12-24	Methods and compounds for the synthesis of oligonucleotides and the oligonucleotides thereby produced
AU4329396A (en)	1996-07-31	Use of 3,4-diphenylchromans
ZA969221B (en)	1998-05-04	Indolealkyl derivatives of benzodioxanmethylamine.
ZA964374B (en)	1997-02-17	A pharmaceutical compositions for inhibiting the growth of cancers.
AU6683296A (en)	1997-03-05	Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers
AU5645396A (en)	1996-10-23	Ascomycins
AU2217797A (en)	1997-10-10	Synthesis of indolylmaleimides
AU3918797A (en)	1998-04-02	Composition for the treatment of rice seeds
AU4224096A (en)	1996-08-08	Use of phenylcyclohexylcarboxamides
AU4157097A (en)	1998-03-06	Synthesis of bisindolylmalimides
AU3691093A (en)	1993-10-21	Methods of inhibiting the growth of multidrug resistant tumors
AU3467697A (en)	1998-01-14	3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
AU4712696A (en)	1996-09-04	The use of heterocyclic compounds

Legal Events

Date	Code	Title	Description
2000-03-16	FGA	Letters patent sealed or granted (standard patent)
2003-03-06	MK14	Patent ceased section 143(a) (annual fees not paid) or expired